Literature DB >> 18463974

Ten years of HER2-directed therapy: still questions after all these years.

Ian E Krop1, Eric P Winer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463974     DOI: 10.1007/s10549-008-0041-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  4 in total

Review 1.  The ethical use of mandatory research biopsies.

Authors:  Erin M Olson; Nancy U Lin; Ian E Krop; Eric P Winer
Journal:  Nat Rev Clin Oncol       Date:  2011-08-02       Impact factor: 66.675

2.  Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology.

Authors:  Jeffrey Peppercorn; Iuliana Shapira; Deborah Collyar; Teresa Deshields; Nancy Lin; Ian Krop; Hans Grunwald; Paula Friedman; Ann H Partridge; Richard L Schilsky; Monica M Bertagnolli
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

3.  Value of CT-Based Radiomics in Predicating the Efficacy of Anti-HER2 Therapy for Patients With Liver Metastases From Breast Cancer.

Authors:  Miao He; Yu Hu; Dongdong Wang; Meili Sun; Huijie Li; Peng Yan; Yingxu Meng; Ran Zhang; Li Li; Dexin Yu; Xiuwen Wang
Journal:  Front Oncol       Date:  2022-04-07       Impact factor: 5.738

4.  Augmented inhibition of angiogenesis by combination of HER2 antibody chA21 and trastuzumab in human ovarian carcinoma xenograft.

Authors:  Anli Zhang; Guodong Shen; Ting Zhao; Guihong Zhang; Jing Liu; Lihua Song; Wei Wei; Ling Bing; Zhengsheng Wu; Qiang Wu
Journal:  J Ovarian Res       Date:  2010-08-19       Impact factor: 4.234

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.